SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001367644-13-000051
Filing Date
2013-08-06
Accepted
2013-08-05 18:43:37
Documents
20
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q063013.htm 10-Q 725214
2 exhibit10_1.htm EX-10.1 940
3 exhibit10_1.gif GRAPHIC 95052
4 exhibit10-2.htm EX-10.2 6003
5 exhibit102.gif GRAPHIC 85663
6 exhibit10-3.htm EX-10.3 31446
7 exhibit10-3.gif GRAPHIC 86737
8 exhibit10-4.htm EX-10.4 20793
9 exhibit10-4.gif GRAPHIC 86528
10 exhibit12.htm EX-12.1 49420
11 exhibit31_1.htm EX-31.1 10187
12 exhibit31_2.htm EX-31.2 10184
13 exhibit32_1.htm EX-32.1 3616
14 exhibit32_2.htm EX-32.2 3649
  Complete submission text file 0001367644-13-000051.txt   6986607

Data Files

Seq Description Document Type Size
15 ebs-20130630.xml EX-101.INS 553984
16 ebs-20130630.xsd EX-101.SCH 32802
17 ebs-20130630_cal.xml EX-101.CAL 58544
18 ebs-20130630_def.xml EX-101.DEF 176106
19 ebs-20130630_lab.xml EX-101.LAB 586650
20 ebs-20130630_pre.xml EX-101.PRE 340684
Mailing Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850
Business Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850 (301) 795-1800
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33137 | Film No.: 131011409
SIC: 2834 Pharmaceutical Preparations